Liu Zhuqing, Wang Hui, Zhang Xi, Xu Qing
Department of Medical Oncology, Shanghai Tenth People's Hospital, Tongji University, School of Medicine, Shanghai 200072, P.R. China.
Oncol Lett. 2014 Dec;8(6):2661-2663. doi: 10.3892/ol.2014.2555. Epub 2014 Sep 24.
Primary malignant melanoma (MM) of the uterine cervix is a rare neoplasm and the overall prognosis of patients with this disease is poor. Immunohistochemical methods and exclusion of other primary melanoma sites are used to confirm the diagnosis. In the present study, the case of a 65-year-old female patient with an MM of the uterine cervix is reported. Diagnosis was confirmed by immunohistochemical methods using human melanoma black 45 antibody and S-100 protein. The tumor was identified as stage IB1 using the International Federation of Gynecology and Obstetrics classification. Chest X-ray and abdominopelvic computed tomography results were normal. The patient subsequently underwent a radical hysterectomy with bilateral salpingo-oophorectomy and pelvic lymphadenectomy. Following combined radical surgery and chemotherapy, complete remission of the tumor was achieved. The patient has since been well for 30 months without recurrence subsequent to the surgery.
子宫颈原发性恶性黑色素瘤(MM)是一种罕见的肿瘤,该疾病患者的总体预后较差。免疫组织化学方法以及排除其他原发性黑色素瘤部位用于确诊。在本研究中,报告了一名65岁患有子宫颈MM的女性患者病例。通过使用人黑色素瘤黑色45抗体和S-100蛋白的免疫组织化学方法确诊。根据国际妇产科联合会分类,该肿瘤被确定为IB1期。胸部X线和腹盆腔计算机断层扫描结果正常。患者随后接受了根治性子宫切除术、双侧输卵管卵巢切除术和盆腔淋巴结清扫术。经过联合根治性手术和化疗后,肿瘤实现完全缓解。自手术以来,患者状况良好,术后30个月无复发。